Back to Results
First PageMeta Content
Cell cycle / CDK inhibitor / Cyclin-dependent kinase / Retinoblastoma protein / Retinoblastoma / Brain tumor / Protein P16 / Crenolanib / Biology / Cell biology / Proteins


NCI Protocol #: PBTC-042 Local Protocol #: PBTC-042 Version date: 03 July 2014 Protocol Abstract and Schema PBTC-042: Phase I study of CDK 4-6 inhibitor PD[removed]in children with recurrent,
Add to Reading List

Document Date: 2014-11-06 17:44:32

Open Document

File Size: 82,50 KB

Share Result on Facebook

Company

Pfizer Corporation / /

Country

United States / /

MedicalCondition

cancers / tumor / recurrent CNS tumors / form cancer / refractory central nervous system tumors / cancer / pediatric CNS tumors / tumors / disease / retinoblastoma / cataract / cataracts / CNS tumors / /

MedicalTreatment

chemotherapy / /

Technology

pharmacokinetics / PBTC-042 Local Protocol / 1 NCI Protocol / 2014 Protocol / /

SocialTag